Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 17;59(1):e02226-20.
doi: 10.1128/JCM.02226-20. Print 2020 Dec 17.

Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences' SARS-CoV-2 Multiplex Amplicon Sequencing Panel

Affiliations

Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences' SARS-CoV-2 Multiplex Amplicon Sequencing Panel

Amin Addetia et al. J Clin Microbiol. .
No abstract available

Keywords: SARS-CoV-2; amplicon panel; genome; genome recovery.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Evaluation of the Swift Biosciences’ SARS-CoV-2 multiplex amplicon sequencing panel. (A) Complete genomes were recovered from all samples with a CT value of ≤32.16 and a CT value as high as 36.77. Samples for which complete genomes (>95% genome coverage) were recovered are highlighted in purple. Partial genomes are highlighted in gold. (B) SARS-CoV-2 sequences were highly enriched in the sequencing libraries as measured by the percentage of reads mapping to the reference genome for SARS-CoV-2 (NCBI accession no. NC_045512.2). Complete genomes were recovered for samples highlighted in purple, while partial genomes were recovered for those highlighted in gold. (C) The genome coverage between nucleotides 201 and 29741 of the SARS-CoV-2 reference genome is even. The 5th and 95th percentiles of coverage at each position across the 41 samples with a mean depth of >100× are plotted in purple. A 250-nucleotide window moving average is represented in gold. (D) The 46 SARS-CoV-2 samples with complete genomes belong to both major SARS-CoV-2 lineages. A phylogenetic tree with the 46 SARS-CoV-2 genomes recovered in this report and 109 other global strains was constructed with FastTree version 2.1.1. Strains belonging to lineage A are highlighted in purple, while those belonging to lineage B are highlighted in gold. Those genomes sequenced in this report are circled in black. SNV, single nucleotide variation.

References

    1. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. 2020. The proximal origin of SARS-CoV-2. Nat Med 26:450–452. doi:10.1038/s41591-020-0820-9. - DOI - PMC - PubMed
    1. Deng X, Gu W, Federman S, Du Plessis L, Pybus OG, Faria NR, Wang C, Yu G, Bushnell B, Pan C-Y, Guevara H, Sotomayor-Gonzalez A, Zorn K, Gopez A, Servellita V, Hsu E, Miller S, Bedford T, Greninger AL, Roychoudhury P, Starita LM, Famulare M, Chu HY, Shendure J, Jerome KR, Anderson C, Gangavarapu K, Zeller M, Spencer E, Andersen KG, MacCannell D, Paden CR, Li Y, Zhang J, Tong S, Armstrong G, Morrow S, Willis M, Matyas BT, Mase S, Kasirye O, Park M, Masinde G, Chan C, Yu AT, Chai SJ, Villarino E, Bonin B, Wadford DA, Chiu CY. 2020. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science 369:582–587. doi:10.1126/science.abb9263. - DOI - PMC - PubMed
    1. Fauver JR, Petrone ME, Hodcroft EB, Shioda K, Ehrlich HY, Watts AG, Vogels CBF, Brito AF, Alpert T, Muyombwe A, Razeq J, Downing R, Cheemarla NR, Wyllie AL, Kalinich CC, Ott IM, Quick J, Loman NJ, Neugebauer KM, Greninger AL, Jerome KR, Roychoudhury P, Xie H, Shrestha L, Huang M-L, Pitzer VE, Iwasaki A, Omer SB, Khan K, Bogoch II, Martinello RA, Foxman EF, Landry ML, Neher RA, Ko AI, Grubaugh ND. 2020. Coast-to-coast spread of SARS-CoV-2 during the early epidemic in the United States. Cell 181:990–996.E5. doi:10.1016/j.cell.2020.04.021. - DOI - PMC - PubMed
    1. Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z, Cui J, Lu J. 2020. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 7:1012–1023. doi:10.1093/nsr/nwaa036. - DOI - PMC - PubMed
    1. Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI, McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, Montefiori DC, Angyal A, Brown RL, Carrilero L, Green LR, Groves DC, Johnson KJ, Keeley AJ, Lindsey BB, Parsons PJ, Raza M, Rowland-Jones S, Smith N, Tucker RM, Wang D, Wyles MD. 2020. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182:812–827.E19. doi:10.1016/j.cell.2020.06.043. - DOI - PMC - PubMed

LinkOut - more resources